Abiopharma

News list

Director Rafferty Michael P 🟢 acquired 1.5K shares of Triumph Financial, Inc. (TFIN) Transaction Date: May 01, 2026 | Filing ID: 030637

Full text

News bot May 5, 2026, 8:32 p.m.
🔍 Rafferty Michael P (Director)

Company: Triumph Financial, Inc. (TFIN)

Report Date: 2026-05-01
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 1
- Total shares acquired: 1,528
- Total shares held: 9,338
Detailed Transactions and Holdings:
- Acquired 1,528 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 38,571.00 | transaction_form_type: 4 | Footnotes: F1, F2
- Holds 0 shares of Depository Shares (Direct)
  Date: 2026-05-01 | Code: H | shares_owned_after: 9,338.00 | Footnotes: F3
Footnotes:
- F1: Shares represented by time-vested restricted stock units that vest one year from date of award.
- F2: Consists of (i) 20,909 shares of common stock of Issuer beneficially owned by reporting person, (ii) 1,258 shares of restricted stock or restricted stock units of the reporting person subject to future vesting requirements, and (iii) 16,134 shares of common stock of Issuer beneficially owned jointly with reporting person's spouse Linda Rafferty.
- F3: Each Depository Share represents a 1/40th interest in a share of the Issuer's 7.125% Series C Fixed Rate Non-Cumulative Perpetual Preferred Stock, par value $0.01 per share. Shares purchased in an underwritten public offering.